Study protocol for assessment of the coagulation potential of concomitantly used factor VIII concentrates in patients with haemophilia A with emicizumab prophylaxis (CAGUYAMA Study): a multicentre open-label non-randomised clinical trial.
BMJ open（2023）
Abstract
jRCTs051210137.
MoreTranslated text
Key words
factor viii concentrates,emicizumab prophylaxis,coagulation potential,open-label,non-randomised
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined